Danaher Corporation

Current directors and officers who also hold a role at another S&P 500 company.

• Teri ListLULU · DirectorMSFT · DirectorV · Director
• Brian W. EllisETR · Director
• Linda FillerVLTO · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Oct 13, 2026

   Director Appointments On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately. Each of Mr. Comas and Dr. Hershberg will serve until the Company’s next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal. Dr. Hershberg has also been appointed to serve as a member of the Science and Technology Committee of the Board. Daniel L. Comas, age 62, joined the Company in 1991 and served as Executive Vice President from April 2005 through December 2020, including as Chief Financial Officer from April 2005 through December 2018. During his tenure, Mr.

   Read the 8-K filing
2. Aug 3, 2026

   Appointment of Julie Sawyer Montgomery as President and Chief Executive Officer On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”). The Board also appointed Ms. Sawyer Montgomery to the Board and to each of the Executive, Finance and Science & Technology Committees of the Board, in each case effective as of the Effective Date. There are no arrangements or understandings between Ms. Sawyer Montgomery and any other person pursuant to which Ms. Sawyer Montgomery was selected as an officer or director of the Company, and there are no family relationships between Ms. Sawyer Montgomery and any director or executive officer of the Company.

   Read the 8-K filing
3. May 7, 2026

   On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in

   Read the 8-K filing
4. Feb 10, 2026

   On February 5, 2026, Jessica L. Mega notified Danaher Corporation’s (“Danaher”) Board of Directors (“Board”) of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations. Dr. Mega’s decision was not the result of any disagreement with Danaher on any matter relating to Danaher’s operations, policies or practices.

   Read the 8-K filing
5. Nov 6, 2025

   On November 6, 2025, John T. Schwieters notified Danaher’s Board of Directors (“Board”) that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting. Mr. Schwieters’ decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The size of the Board will be reduced from thirteen to twelve members as of the time of Mr. Schwieters’ retirement.

   Read the 8-K filing
6. Jul 31, 2025

   On July 28, 2025, Brian W. Ellis, Senior Vice President and General Counsel of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he plans to relinquish his role as General Counsel as of August 25, 2025, after which he will continue in an executive officer role as Senior Vice President of the Company until his retirement from the Company on February 28, 2026.

   Read the 8-K filing
7. Jul 24, 2025

   On July 21, 2025, Matthew M. McGrew, Executive Vice President and Chief Financial Officer of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he plans to relinquish his role as Chief Financial Officer as of February 28, 2026, after which he will continue as an Executive Vice President of the Company. Effective February 28, 2026, Matthew E. Gugino will succeed Mr. McGrew as Executive Vice President-Chief Financial Officer. Mr. Gugino, 43, currently serves as Danaher’s Vice President-Corporate FP&A and Group CFO with responsibility for the Life Sciences Innovations businesses. Since joining Danaher in 2013, Mr. Gugino has served in a series of progressively more responsible positions in the Company’s finance and investor relations organizations, including as Vice President-Investor Relations from 2014 to March 2022.

   Read the 8-K filing
8. Feb 20, 2025

   Director Appointment On February 20, 2025, the Board of Directors (“Board”) of Danaher Corporation (“Danaher” or the “Company”) appointed Charles W. Lamanna to the Board, with a term expiring at Danaher’s 2025 annual meeting of shareholders. Mr. Lamanna was also appointed to the Science & Technology Committee of the Board. As a non-employee director, Mr. Lamanna will receive the same compensation paid to the other non-employee directors of Danaher as disclosed in Exhibit 10.24 to Danaher’s Annual Report on Form 10-K for the year ended December 31, 2024 (which exhibit is incorporated by reference herein) including without limitation an annual equity award. Mr.

   Read the 8-K filing
9. Dec 11, 2024

   On December 9, 2024, Pardis C. Sabeti notified Danaher’s Board of Directors of her retirement from the Danaher Board as of December 10, 2024, due to time commitments related to her other professional obligations. Dr. Sabeti’s decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

   Read the 8-K filing
10. Jun 20, 2024

    (b) On June 16, 2024, Joakim Weidemanis, Executive Vice President of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he will step down from such position as of July 1, 2024. Following July 1, 2024, Mr. Weidemanis is expected to remain employed with, and provide transition services to, Danaher through September 30, 2024. (e) In connection with Mr. Weidemanis’ decision to step down from his role as Executive Vice President, he and Danaher have entered into a Transition Agreement to govern Mr. Weidemanis’ employment with Danaher from July 1, 2024 through September 30, 2024 (“Transition Period”). The Transition Agreement provides that Mr. Weidemanis’ salary during the Transition Period continues at the same annual rate as immediately preceding such period; Mr.

    Read the 8-K filing
11. Feb 14, 2024

    On February 12, 2024, Walter G. Lohr, Jr. notified Danaher’s Board of Directors that he has decided not to stand for reelection at the Company’s annual meeting of shareholders to be held on May 7, 2024, and will retire from the Danaher Board as of the annual meeting. Mr. Lohr’s decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

    Read the 8-K filing
12. Oct 2, 2023

    In connection with the Separation and Distribution, Jennifer L. Honeycutt (Executive Vice President) submitted her resignation from her position as an executive officer at Danaher (but not at Veralto), effective as of the Distribution.

    Read the 8-K filing
13. Jun 29, 2022

    On June 27, 2022, the Board of Directors (“Board”) of Danaher Corporation (“Danaher”) increased the size of Danaher’s Board from thirteen to fourteen members and appointed Feroz Dewan to the Board to fill the newly-created vacancy, with a term expiring at Danaher’s 2023 annual meeting of shareholders. Mr. Dewan was also appointed to the Science & Technology Committee of the Board. As a non-employee director, Mr. Dewan will receive the same compensation paid to the other non-employee directors of Danaher as disclosed in Exhibit 10.22 to Danaher’s Annual Report on Form 10-K for the year ended December 31, 2021 (which exhibit is incorporated by reference herein) including without limitation an annual equity award. Mr.

    Read the 8-K filing
14. Apr 1, 2022

    As previously announced, as of April 1, 2022, Angela S. Lalor has stepped down, and Georgeann F. Couchara has succeeded her, as Senior Vice President-Human Resources. Following April 1, 2022, Ms. Lalor will continue performing services for Danaher on a part-time basis and effective as of such date she will receive the following compensation: base salary at an annual rate of $198,514; and cash incentive compensation for the period from April 1 through December 31, 2022 at a target amount equal to 115% of her salary for such period.

    Read the 8-K filing
15. Dec 8, 2021

    On December 7, 2021, the Board of Directors of Danaher Corporation (the “Company”) amended and restated the Company’s 2007 Omnibus Incentive Plan (the “Plan”) to amend the “Years of Service” definition used for purposes of determining Early Retirement eligibility (capitalized terms used in this description have the meaning set forth in the Plan). The amendment gives the Administrator the discretion to provide (either initially or subsequent to the grant of the relevant Award) that with respect to any Award granted to a Participant during the first year following the date as of which such Participant’s employer became an Acquired Subsidiary, the Participant’s employment with the Acquired Subsidiary before it was acquired by Danaher does not count toward “Years of Service” eligibility.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.